CIENCIASMEDICASNEWS: Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic | NIH: National Institute of Allergy and Infectious Diseases

viernes, 28 de enero de 2022

Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic | NIH: National Institute of Allergy and Infectious Diseases

Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)